Nordic Bioproducts Group announces the opening of its commercial-scale production facility for microcrystalline cellulose (MCC) and other cellulose derivatives in Lappeenranta, Finland. This first-of-its-kind facility represents a leap in manufacturing, enabling continuous and sustainable production at scale.